SCHEMBL21066355

SCHEMBL21066355

O=[N+]([O-])c1cc(Cl)c(OC(F)(F)F)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
CYP3A4 P08684 2/20 0.41
TDP1 Q9NUW8 4/20 0.40
TSHR P16473 3/20 0.40
HPGD P15428 2/20 0.40
ALOX15 P16050 2/20 0.40
HIF1A Q16665 1/20 0.40
TXNRD1 Q16881 1/20 0.40
TXNRD3 Q86VQ6 1/20 0.40
TXNRD2 Q9NNW7 1/20 0.40
GPR35 Q9HC97 4/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TTR P02766 1/20 0.38
PPOX P50336 1/20 0.38
MAPK1 P28482 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TP53 P04637 1/20 0.38
DPP4 P27487 1/20 0.37
PREP P48147 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19899524 0.94 ALDH1A1 (0.41) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL21066333 0.83 EPHX2 (0.39) ALDH1A1TDP1TSHRHPGDALOX15
SCHEMBL10333537 0.82 TSHR (0.43) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL8083327 0.80 TDP1 (0.44) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL21066389 0.79 EPHX2 (0.39) ALDH1A1TDP1TSHRHPGDALOX15
SCHEMBL305627 0.79 DPP4 (0.50) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL1192895 0.78 ALDH1A1 (0.45) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL1023324 0.76 ALDH1A1 (0.47) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL305109 0.75 ALDH1A1 (0.55) ALDH1A1CYP3A4TDP1TSHRHPGD
SCHEMBL3259695 0.75 MAPT (0.46) ALDH1A1CYP3A4GPR35MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190194179-A1 ANTIBIOTIC COMPOUNDS DISCUVA LTD. (GB) 2019-06-27 US disclosed
US-20190194179-A1 ANTIBIOTIC COMPOUNDS DISCUVA LTD. (GB) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194179-A1 ANTIBIOTIC COMPOUNDS B3GNT2, RPN2, RPN1 ALDH1A1 3333/4885CYP3A4 2095/4885TDP1 3374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.